舒泰神公告,公司因与关联方 昭衍新药 的特定关联交易违反首发承诺,收到深交所问询函及北京证监局监管谈话决定。公司已采取整改措施,包括协商收益返还、规范关联交易管理,并组织相关人员学习证券法规。
Source Link舒泰神公告,公司因与关联方 昭衍新药 的特定关联交易违反首发承诺,收到深交所问询函及北京证监局监管谈话决定。公司已采取整改措施,包括协商收益返还、规范关联交易管理,并组织相关人员学习证券法规。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.